IP Library Granted Patent US 9,700,368
Granted Patent B2
US 9,700,368 · App. 13/273,001 · Granted Jul 11, 2017

System and method for electrically ablating tissue of a patient

Inventors: Peter Callas (Castro Valley, CA); David Warden (Belmont, CA); Robert M. Pearson (San Jose, CA)
A61B18/14A61B34/25A61B2018/0016A61B2018/00577A61B2018/00613A61B2018/00642A61B2018/143
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,700,368
App. No.
13/273,001
Granted
Jul 11, 2017
Kind
B2
Abstract

System for electrically ablating tissue of a patient through a plurality of electrodes includes a memory, a processor and a treatment control module stored in the memory and executable by the processor. The treatment control module generates an estimated treatment region based on the number of electrical pulses to be applied.

Claims (30)

1. A system for planning a treatment of non-thermally and electrically ablating tissue of a patient through a plurality of electrodes comprising:

a memory;

a processor coupled to the memory;

a display device connected to the processor, the display device displaying a user interface, the user interface allowing the user to input and change at least one treatment parameter;

a treatment control module stored in the memory and executable by the processor, the treatment control module adapted to:

receive parameters for a target ablation region;

select a number of electrical pulses based on the target ablation region and the positions of the electrodes; and

generate an estimated treatment region based on the number of electrical pulses to be applied through the electrodes the generated estimated treatment region displayed on the display prior to a treatment procedure, the estimated treatment region being a non-thermally ablated tissue region, altering the generated estimated treatment region by changing at least one treatment parameter on the user interface.

2. The system of claim 1 , wherein the treatment control module further generates the estimated treatment region based on the number and positions of electrodes.

3. The system of claim 1 , wherein the treatment control module further generates the treatment region based on the positions of the electrodes.

4. The system of claim 1 , wherein the treatment control module displays on the display device a target ablation region superimposed with the generated estimated treatment region.

5. The system of claim 1 , wherein the treatment control module:

generates a plurality of estimated treatment regions based on different numbers of pulses to be applied; and

selects an optimal number of pulses to be applied based on the generated treatment regions.

6. The system of claim 1 , wherein the treatment control module:

generates a plurality of estimated treatment regions based on different numbers of pulses to be applied and different numbers of electrodes; and

selects an optimal number of electrodes to be applied and an optimal number of electrodes based on the generated treatment regions.

7. The system of claim 1 , wherein the treatment control module selects a pulse width based on a target ablation region.

8. The system of claim 1 , wherein the plurality of electrodes includes at least three electrodes (E 1 , E 2 and E 3 ), the system further comprising a pulse generator adapted to deliver, in sequence, at least one pulse to a first pair of electrodes (E 1 -E 2 ), at least one pulse to a second pair of electrodes (E 2 -E 3 ) and at least one other pulse to the first pair of electrodes (E 1 -E 2 ).

9. The system of claim 1 , wherein the plurality of electrodes includes at least three electrodes (E 1 , E 2 and E 3 ), the system further comprising a pulse generator, under the control of the treatment control module, adapted to deliver, in sequence, a set of pulses to a first pair of electrodes (E 1 -E 2 ), a set of pulses to a second pair of electrodes (E 2 -E 3 ), a set of pulses to a third pair of electrodes (E 3 -E 1 ), and then repeat the same sequence of pulse delivery.

10. The system of claim 1 , wherein the treatment control module further generates the estimated treatment region using a Cassini oval equation.

11. The system of claim 10 , wherein treatment control module:

further generates the estimated treatment region using the following Cassini oval equation or its equivalent Cartesian equation:

r 2 =a 2 cos(2*theta)+/−sqrt( b 4 −a 4 sin 2(2*theta))

wherein a is the distance from the origin to each electrode and b is a constant; and adjusts the constant b based on the number of pulses to be applied.

12. The system of claim 1 , wherein the treatment control module further generates the estimated treatment region according to a predetermined positive relationship between the number of pulses and the size of the ablation region.

13. The system of claim 1 , wherein the treatment control module further generates the estimated treatment region according to a predetermined positive non-linear relationship between the number of pulses and the size of the ablation region.

14. The system of claim 1 , wherein the treatment control module further generates the estimated treatment region according to a tissue conductivity of a tissue region of a patient to be treated.

15. The system of claim 1 , wherein the treatment control module controls a pulse generator to generate two or more sequences of pulses in which an inter-sequence delay is greater than an inter-pulse delay within one sequence.

16. The system of claim 1 , wherein the at least one treatment parameter changed is the depth of the plurality of electrodes.

Assignments (10)
RELEASE OF SECURITY INTEREST Recorded Jun 8, 2023
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: ANGIODYNAMICS, INC.
Reel/Frame 063940/0362 →
SECURITY INTEREST Recorded Aug 31, 2022
From: ANGIODYNAMICS, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 061360/0668 →
RELEASE OF SECURITY INTEREST Recorded Aug 31, 2022
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: ANGIODYNAMICS, INC.
Reel/Frame 061363/0446 →
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Jun 5, 2019
From: ANGIODYNAMICS, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 049371/0657 →
RELEASE OF SECURITY INTEREST Recorded Nov 14, 2016
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: ANGIODYNAMICS, INC.
Reel/Frame 040688/0540 →
SECURITY INTEREST Recorded Nov 8, 2016
From: ANGIODYNAMICS, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 040613/0049 →
SECURITY AGREEMENT Recorded Sep 30, 2013
From: ANGIODYNAMICS, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 031315/0720 →
RELEASE OF SECURITY INTEREST Recorded Sep 30, 2013
From: JPMORGAN CHASE BANK N.A., AS ADMINISTRATIVE AGENT
To: ANGIODYNAMICS, INC.
Reel/Frame 031315/0361 →
SECURITY AGREEMENT Recorded May 23, 2012
From: ANGIODYNAMICS, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 028260/0329 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 10, 2011
From: CALLAS, PETER; WARDEN, DAVID; PEARSON, ROBERT M.
To: ANGIODYNAMICS, INC.
Reel/Frame 027209/0961 →
Continuity (2)
Provisional Application 61392905 · Oct 13, 2010
Related Publication 20120095459A1 · Apr 19, 2012